Concepedia

Publication | Open Access

Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08

DOIFull Paper Access

45

Citations

14

References

2020

Year

Toshiki Masuishi, Akihito Tsuji, Masahito Kotaka, Masato Nakamura, Mitsugu Kochi, Akinori Takagane, Ken Shimada, Tadamichi Denda, Yoshihiko Segawa, Hiroaki Tanioka,
British Journal of Cancer

References

YearCitations

Page 1